Redhill Capital

Redhill Capital is a private equity firm based in Guangzhou, China, established in 2018. The firm specializes in early-stage investments, focusing on the healthcare and technology sectors. It primarily invests in medical industry companies, including innovative medical technologies such as high-value consumables, in-vitro diagnostic reagents, consumer healthcare, and digital health.

The firm's investment strategy involves delivering operational consulting and intelligent solutions for the retail industry. Redhill Capital has a notable track record, with investments in companies like Be Light, Kofun Medical, and Heyuan Biotech. The firm is known for its rare combination of expertise in medical technology investments, profound industry understanding, and impressive investment performance.

Redhill Capital's team comprises professionals with rich experiences in investment banking, private banking, family office, venture capital, and wealth management. The firm's approach emphasizes direct engagement with committed management teams to explore exciting investment opportunities with unique value and growth potential.